Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ODIn-AF: Prevention of Silent Cerebral Thromboembolism After AF Ablation
2013-003492-35Phase 3Terminated
- Sponsor
- University of Bonn
- Start
- Mar 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of dabigatran in Atrial fibrillation (AFib), brain infarction and cerebral sinovenous thrombosis (CSVT) (2 arms), sponsored by University of Bonn. Started Mar 2015; status: terminated.
02
Drugs
dabigatran
03
Conditions
Atrial fibrillation (AFib)brain infarctioncerebral sinovenous thrombosis (CSVT)
Beyond the preview
Go deeper on 2013-003492-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003492-35.